Cargando…
Weekly versus three weeks chemotherapy for advanced ovarian cancer: a meta-analysis
AIM: Three weeks paclitaxel and carboplatin has been considered the standard of care for primary treatment of ovarian cancer (OC). Whether weekly therapy will further improve the clinical outcomes or not is still unclear. We conducted a meta-analysis to compare the two regimens. METHOD: Articles wer...
Autores principales: | Marchetti, Claudia, De Felice, Francesca, Musella, Angela, Palaia, Innocenza, Monti, Marco, Musio, Daniela, Muzii, Ludovico, Tombolini, Vincenzo, Panici, Pierluigi Benedetti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295464/ https://www.ncbi.nlm.nih.gov/pubmed/27509061 http://dx.doi.org/10.18632/oncotarget.11094 |
Ejemplares similares
-
Immunotherapy of Ovarian Cancer: The Role of Checkpoint Inhibitors
por: De Felice, Francesca, et al.
Publicado: (2015) -
Risk-reducing salpingo-oophorectomy: a meta-analysis on impact on ovarian cancer risk and all cause mortality in BRCA 1 and BRCA 2 mutation carriers
por: Marchetti, Claudia, et al.
Publicado: (2014) -
Efficacy and toxicity of bevacizumab in recurrent ovarian disease: an update meta-analysis on phase III trials
por: Marchetti, Claudia, et al.
Publicado: (2015) -
Survival Nomograms after Curative Neoadjuvant Chemotherapy and Radical Surgery for Stage IB2-IIIB Cervical Cancer
por: Marchetti, Claudia, et al.
Publicado: (2018) -
Fertility preservation in gynaecologic cancers
por: De Felice, Francesca, et al.
Publicado: (2018)